Mesothelin Is a Malignant Factor and Therapeutic Vaccine Target for Pancreatic Cancer

Pancreas - United States
doi 10.1097/01.mpa.0000297731.91864.2c
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Annexin A8 Is a Prognostic Marker and Potential Therapeutic Target for Pancreatic Cancer

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2015English

MERTK Is a Potential Therapeutic Target in Malignant Melanoma

Cancer Discovery
Oncology
2013English

Nestin as a Novel Therapeutic Target for Pancreatic Cancer via Tumor Angiogenesis

International Journal of Oncology
Cancer ResearchOncology
2012English

Role of Fibroblast Growth Factor Receptor 2 in Pancreatic Cancer: Potential Target for New Therapeutic Approach?

Pancreatic Disorders and Therapy
2015English

Fibroblast Growth Factor Receptor 3 Is a Rational Therapeutic Target in Bladder Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Streptococcus Iniae Phosphoglucomutase Is a Virulence Factor and a Target for Vaccine Development

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2005English

Mesothelin, a Novel Immunotherapy Target for Triple Negative Breast Cancer

Breast Cancer Research and Treatment
Cancer ResearchOncology
2012English

JMJD6 Is a Tumorigenic Factor and Therapeutic Target in Neuroblastoma

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Polyisoprenylated Methylated Protein Methyl Esterase: A Putative Biomarker and Therapeutic Target for Pancreatic Cancer

European Journal of Medicinal Chemistry
MedicineOrganic ChemistryDrug DiscoveryPharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy